OCULAR THERAPEUTIX revenue breakdown overview

OCULAR THERAPEUTIX revenue for the last year amounted to 49.21 M CHF, the most of which — 48.72 M CHF — came from its highest performing source at the moment, Bioresorbable Hydrogel Platform Technology, the year earlier bringing 46.66 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought OCULAR THERAPEUTIX 49.21 M CHF, and the year before that — 47.62 M CHF.